Global Neuroblastoma Treatment Market Research Report 2024(Status and Outlook)
Report Overview:
Neuroblastoma treatment includes medical interventions and therapies used to manage neuroblastoma, a type of cancer that affects the sympathetic nervous system, typically occurring in young children.
The Global Neuroblastoma Treatment Market Size was estimated at USD 461.98 million in 2023 and is projected to reach USD 567.89 million by 2029, exhibiting a CAGR of 3.50% during the forecast period.
This report provides a deep insight into the global Neuroblastoma Treatment market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Neuroblastoma Treatment Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Neuroblastoma Treatment market in any manner.
Global Neuroblastoma Treatment Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Seattle Children’s
CureSearch
Texas Children’s
NANT
Sino Biopharmaceutical
Jiangsu Hengrui Medicine Co.,Ltd.
Fosun Pharmaceutical
Novartis
Juno Therapeutics
Kite Pharma
Adaptimmune
Market Segmentation (by Type)
Combination Chemotherapy
Monoclonal Antibody Therapy
Vaccine Therapy
Chimeric Antigen Receptor T-Cell Immunotherapy
Oncolytic Virus Therapy
Market Segmentation (by Application)
Hospitals
Clinics
Others
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Neuroblastoma Treatment Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
Neuroblastoma treatment includes medical interventions and therapies used to manage neuroblastoma, a type of cancer that affects the sympathetic nervous system, typically occurring in young children.
The Global Neuroblastoma Treatment Market Size was estimated at USD 461.98 million in 2023 and is projected to reach USD 567.89 million by 2029, exhibiting a CAGR of 3.50% during the forecast period.
This report provides a deep insight into the global Neuroblastoma Treatment market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Neuroblastoma Treatment Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Neuroblastoma Treatment market in any manner.
Global Neuroblastoma Treatment Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Seattle Children’s
CureSearch
Texas Children’s
NANT
Sino Biopharmaceutical
Jiangsu Hengrui Medicine Co.,Ltd.
Fosun Pharmaceutical
Novartis
Juno Therapeutics
Kite Pharma
Adaptimmune
Market Segmentation (by Type)
Combination Chemotherapy
Monoclonal Antibody Therapy
Vaccine Therapy
Chimeric Antigen Receptor T-Cell Immunotherapy
Oncolytic Virus Therapy
Market Segmentation (by Application)
Hospitals
Clinics
Others
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Neuroblastoma Treatment Market
- Overview of the regional outlook of the Neuroblastoma Treatment Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Neuroblastoma Treatment Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Neuroblastoma Treatment
1.2 Key Market Segments
1.2.1 Neuroblastoma Treatment Segment by Type
1.2.2 Neuroblastoma Treatment Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 NEUROBLASTOMA TREATMENT MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Neuroblastoma Treatment Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Neuroblastoma Treatment Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 NEUROBLASTOMA TREATMENT MARKET COMPETITIVE LANDSCAPE
3.1 Global Neuroblastoma Treatment Sales by Manufacturers (2019-2024)
3.2 Global Neuroblastoma Treatment Revenue Market Share by Manufacturers (2019-2024)
3.3 Neuroblastoma Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Neuroblastoma Treatment Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Neuroblastoma Treatment Sales Sites, Area Served, Product Type
3.6 Neuroblastoma Treatment Market Competitive Situation and Trends
3.6.1 Neuroblastoma Treatment Market Concentration Rate
3.6.2 Global 5 and 10 Largest Neuroblastoma Treatment Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 NEUROBLASTOMA TREATMENT INDUSTRY CHAIN ANALYSIS
4.1 Neuroblastoma Treatment Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF NEUROBLASTOMA TREATMENT MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 NEUROBLASTOMA TREATMENT MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Neuroblastoma Treatment Sales Market Share by Type (2019-2024)
6.3 Global Neuroblastoma Treatment Market Size Market Share by Type (2019-2024)
6.4 Global Neuroblastoma Treatment Price by Type (2019-2024)
7 NEUROBLASTOMA TREATMENT MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Neuroblastoma Treatment Market Sales by Application (2019-2024)
7.3 Global Neuroblastoma Treatment Market Size (M USD) by Application (2019-2024)
7.4 Global Neuroblastoma Treatment Sales Growth Rate by Application (2019-2024)
8 NEUROBLASTOMA TREATMENT MARKET SEGMENTATION BY REGION
8.1 Global Neuroblastoma Treatment Sales by Region
8.1.1 Global Neuroblastoma Treatment Sales by Region
8.1.2 Global Neuroblastoma Treatment Sales Market Share by Region
8.2 North America
8.2.1 North America Neuroblastoma Treatment Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Neuroblastoma Treatment Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Neuroblastoma Treatment Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Neuroblastoma Treatment Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Neuroblastoma Treatment Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Seattle Children’s
9.1.1 Seattle Children’s Neuroblastoma Treatment Basic Information
9.1.2 Seattle Children’s Neuroblastoma Treatment Product Overview
9.1.3 Seattle Children’s Neuroblastoma Treatment Product Market Performance
9.1.4 Seattle Children’s Business Overview
9.1.5 Seattle Children’s Neuroblastoma Treatment SWOT Analysis
9.1.6 Seattle Children’s Recent Developments
9.2 CureSearch
9.2.1 CureSearch Neuroblastoma Treatment Basic Information
9.2.2 CureSearch Neuroblastoma Treatment Product Overview
9.2.3 CureSearch Neuroblastoma Treatment Product Market Performance
9.2.4 CureSearch Business Overview
9.2.5 CureSearch Neuroblastoma Treatment SWOT Analysis
9.2.6 CureSearch Recent Developments
9.3 Texas Children’s
9.3.1 Texas Children’s Neuroblastoma Treatment Basic Information
9.3.2 Texas Children’s Neuroblastoma Treatment Product Overview
9.3.3 Texas Children’s Neuroblastoma Treatment Product Market Performance
9.3.4 Texas Children’s Neuroblastoma Treatment SWOT Analysis
9.3.5 Texas Children’s Business Overview
9.3.6 Texas Children’s Recent Developments
9.4 NANT
9.4.1 NANT Neuroblastoma Treatment Basic Information
9.4.2 NANT Neuroblastoma Treatment Product Overview
9.4.3 NANT Neuroblastoma Treatment Product Market Performance
9.4.4 NANT Business Overview
9.4.5 NANT Recent Developments
9.5 Sino Biopharmaceutical
9.5.1 Sino Biopharmaceutical Neuroblastoma Treatment Basic Information
9.5.2 Sino Biopharmaceutical Neuroblastoma Treatment Product Overview
9.5.3 Sino Biopharmaceutical Neuroblastoma Treatment Product Market Performance
9.5.4 Sino Biopharmaceutical Business Overview
9.5.5 Sino Biopharmaceutical Recent Developments
9.6 Jiangsu Hengrui Medicine Co.,Ltd.
9.6.1 Jiangsu Hengrui Medicine Co.,Ltd. Neuroblastoma Treatment Basic Information
9.6.2 Jiangsu Hengrui Medicine Co.,Ltd. Neuroblastoma Treatment Product Overview
9.6.3 Jiangsu Hengrui Medicine Co.,Ltd. Neuroblastoma Treatment Product Market Performance
9.6.4 Jiangsu Hengrui Medicine Co.,Ltd. Business Overview
9.6.5 Jiangsu Hengrui Medicine Co.,Ltd. Recent Developments
9.7 Fosun Pharmaceutical
9.7.1 Fosun Pharmaceutical Neuroblastoma Treatment Basic Information
9.7.2 Fosun Pharmaceutical Neuroblastoma Treatment Product Overview
9.7.3 Fosun Pharmaceutical Neuroblastoma Treatment Product Market Performance
9.7.4 Fosun Pharmaceutical Business Overview
9.7.5 Fosun Pharmaceutical Recent Developments
9.8 Novartis
9.8.1 Novartis Neuroblastoma Treatment Basic Information
9.8.2 Novartis Neuroblastoma Treatment Product Overview
9.8.3 Novartis Neuroblastoma Treatment Product Market Performance
9.8.4 Novartis Business Overview
9.8.5 Novartis Recent Developments
9.9 Juno Therapeutics
9.9.1 Juno Therapeutics Neuroblastoma Treatment Basic Information
9.9.2 Juno Therapeutics Neuroblastoma Treatment Product Overview
9.9.3 Juno Therapeutics Neuroblastoma Treatment Product Market Performance
9.9.4 Juno Therapeutics Business Overview
9.9.5 Juno Therapeutics Recent Developments
9.10 Kite Pharma
9.10.1 Kite Pharma Neuroblastoma Treatment Basic Information
9.10.2 Kite Pharma Neuroblastoma Treatment Product Overview
9.10.3 Kite Pharma Neuroblastoma Treatment Product Market Performance
9.10.4 Kite Pharma Business Overview
9.10.5 Kite Pharma Recent Developments
9.11 Adaptimmune
9.11.1 Adaptimmune Neuroblastoma Treatment Basic Information
9.11.2 Adaptimmune Neuroblastoma Treatment Product Overview
9.11.3 Adaptimmune Neuroblastoma Treatment Product Market Performance
9.11.4 Adaptimmune Business Overview
9.11.5 Adaptimmune Recent Developments
10 NEUROBLASTOMA TREATMENT MARKET FORECAST BY REGION
10.1 Global Neuroblastoma Treatment Market Size Forecast
10.2 Global Neuroblastoma Treatment Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Neuroblastoma Treatment Market Size Forecast by Country
10.2.3 Asia Pacific Neuroblastoma Treatment Market Size Forecast by Region
10.2.4 South America Neuroblastoma Treatment Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Neuroblastoma Treatment by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Neuroblastoma Treatment Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Neuroblastoma Treatment by Type (2025-2030)
11.1.2 Global Neuroblastoma Treatment Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Neuroblastoma Treatment by Type (2025-2030)
11.2 Global Neuroblastoma Treatment Market Forecast by Application (2025-2030)
11.2.1 Global Neuroblastoma Treatment Sales (Kilotons) Forecast by Application
11.2.2 Global Neuroblastoma Treatment Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Neuroblastoma Treatment
1.2 Key Market Segments
1.2.1 Neuroblastoma Treatment Segment by Type
1.2.2 Neuroblastoma Treatment Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 NEUROBLASTOMA TREATMENT MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Neuroblastoma Treatment Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Neuroblastoma Treatment Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 NEUROBLASTOMA TREATMENT MARKET COMPETITIVE LANDSCAPE
3.1 Global Neuroblastoma Treatment Sales by Manufacturers (2019-2024)
3.2 Global Neuroblastoma Treatment Revenue Market Share by Manufacturers (2019-2024)
3.3 Neuroblastoma Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Neuroblastoma Treatment Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Neuroblastoma Treatment Sales Sites, Area Served, Product Type
3.6 Neuroblastoma Treatment Market Competitive Situation and Trends
3.6.1 Neuroblastoma Treatment Market Concentration Rate
3.6.2 Global 5 and 10 Largest Neuroblastoma Treatment Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 NEUROBLASTOMA TREATMENT INDUSTRY CHAIN ANALYSIS
4.1 Neuroblastoma Treatment Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF NEUROBLASTOMA TREATMENT MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 NEUROBLASTOMA TREATMENT MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Neuroblastoma Treatment Sales Market Share by Type (2019-2024)
6.3 Global Neuroblastoma Treatment Market Size Market Share by Type (2019-2024)
6.4 Global Neuroblastoma Treatment Price by Type (2019-2024)
7 NEUROBLASTOMA TREATMENT MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Neuroblastoma Treatment Market Sales by Application (2019-2024)
7.3 Global Neuroblastoma Treatment Market Size (M USD) by Application (2019-2024)
7.4 Global Neuroblastoma Treatment Sales Growth Rate by Application (2019-2024)
8 NEUROBLASTOMA TREATMENT MARKET SEGMENTATION BY REGION
8.1 Global Neuroblastoma Treatment Sales by Region
8.1.1 Global Neuroblastoma Treatment Sales by Region
8.1.2 Global Neuroblastoma Treatment Sales Market Share by Region
8.2 North America
8.2.1 North America Neuroblastoma Treatment Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Neuroblastoma Treatment Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Neuroblastoma Treatment Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Neuroblastoma Treatment Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Neuroblastoma Treatment Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Seattle Children’s
9.1.1 Seattle Children’s Neuroblastoma Treatment Basic Information
9.1.2 Seattle Children’s Neuroblastoma Treatment Product Overview
9.1.3 Seattle Children’s Neuroblastoma Treatment Product Market Performance
9.1.4 Seattle Children’s Business Overview
9.1.5 Seattle Children’s Neuroblastoma Treatment SWOT Analysis
9.1.6 Seattle Children’s Recent Developments
9.2 CureSearch
9.2.1 CureSearch Neuroblastoma Treatment Basic Information
9.2.2 CureSearch Neuroblastoma Treatment Product Overview
9.2.3 CureSearch Neuroblastoma Treatment Product Market Performance
9.2.4 CureSearch Business Overview
9.2.5 CureSearch Neuroblastoma Treatment SWOT Analysis
9.2.6 CureSearch Recent Developments
9.3 Texas Children’s
9.3.1 Texas Children’s Neuroblastoma Treatment Basic Information
9.3.2 Texas Children’s Neuroblastoma Treatment Product Overview
9.3.3 Texas Children’s Neuroblastoma Treatment Product Market Performance
9.3.4 Texas Children’s Neuroblastoma Treatment SWOT Analysis
9.3.5 Texas Children’s Business Overview
9.3.6 Texas Children’s Recent Developments
9.4 NANT
9.4.1 NANT Neuroblastoma Treatment Basic Information
9.4.2 NANT Neuroblastoma Treatment Product Overview
9.4.3 NANT Neuroblastoma Treatment Product Market Performance
9.4.4 NANT Business Overview
9.4.5 NANT Recent Developments
9.5 Sino Biopharmaceutical
9.5.1 Sino Biopharmaceutical Neuroblastoma Treatment Basic Information
9.5.2 Sino Biopharmaceutical Neuroblastoma Treatment Product Overview
9.5.3 Sino Biopharmaceutical Neuroblastoma Treatment Product Market Performance
9.5.4 Sino Biopharmaceutical Business Overview
9.5.5 Sino Biopharmaceutical Recent Developments
9.6 Jiangsu Hengrui Medicine Co.,Ltd.
9.6.1 Jiangsu Hengrui Medicine Co.,Ltd. Neuroblastoma Treatment Basic Information
9.6.2 Jiangsu Hengrui Medicine Co.,Ltd. Neuroblastoma Treatment Product Overview
9.6.3 Jiangsu Hengrui Medicine Co.,Ltd. Neuroblastoma Treatment Product Market Performance
9.6.4 Jiangsu Hengrui Medicine Co.,Ltd. Business Overview
9.6.5 Jiangsu Hengrui Medicine Co.,Ltd. Recent Developments
9.7 Fosun Pharmaceutical
9.7.1 Fosun Pharmaceutical Neuroblastoma Treatment Basic Information
9.7.2 Fosun Pharmaceutical Neuroblastoma Treatment Product Overview
9.7.3 Fosun Pharmaceutical Neuroblastoma Treatment Product Market Performance
9.7.4 Fosun Pharmaceutical Business Overview
9.7.5 Fosun Pharmaceutical Recent Developments
9.8 Novartis
9.8.1 Novartis Neuroblastoma Treatment Basic Information
9.8.2 Novartis Neuroblastoma Treatment Product Overview
9.8.3 Novartis Neuroblastoma Treatment Product Market Performance
9.8.4 Novartis Business Overview
9.8.5 Novartis Recent Developments
9.9 Juno Therapeutics
9.9.1 Juno Therapeutics Neuroblastoma Treatment Basic Information
9.9.2 Juno Therapeutics Neuroblastoma Treatment Product Overview
9.9.3 Juno Therapeutics Neuroblastoma Treatment Product Market Performance
9.9.4 Juno Therapeutics Business Overview
9.9.5 Juno Therapeutics Recent Developments
9.10 Kite Pharma
9.10.1 Kite Pharma Neuroblastoma Treatment Basic Information
9.10.2 Kite Pharma Neuroblastoma Treatment Product Overview
9.10.3 Kite Pharma Neuroblastoma Treatment Product Market Performance
9.10.4 Kite Pharma Business Overview
9.10.5 Kite Pharma Recent Developments
9.11 Adaptimmune
9.11.1 Adaptimmune Neuroblastoma Treatment Basic Information
9.11.2 Adaptimmune Neuroblastoma Treatment Product Overview
9.11.3 Adaptimmune Neuroblastoma Treatment Product Market Performance
9.11.4 Adaptimmune Business Overview
9.11.5 Adaptimmune Recent Developments
10 NEUROBLASTOMA TREATMENT MARKET FORECAST BY REGION
10.1 Global Neuroblastoma Treatment Market Size Forecast
10.2 Global Neuroblastoma Treatment Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Neuroblastoma Treatment Market Size Forecast by Country
10.2.3 Asia Pacific Neuroblastoma Treatment Market Size Forecast by Region
10.2.4 South America Neuroblastoma Treatment Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Neuroblastoma Treatment by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Neuroblastoma Treatment Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Neuroblastoma Treatment by Type (2025-2030)
11.1.2 Global Neuroblastoma Treatment Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Neuroblastoma Treatment by Type (2025-2030)
11.2 Global Neuroblastoma Treatment Market Forecast by Application (2025-2030)
11.2.1 Global Neuroblastoma Treatment Sales (Kilotons) Forecast by Application
11.2.2 Global Neuroblastoma Treatment Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Neuroblastoma Treatment Market Size Comparison by Region (M USD)
Table 5. Global Neuroblastoma Treatment Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Neuroblastoma Treatment Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Neuroblastoma Treatment Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Neuroblastoma Treatment Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neuroblastoma Treatment as of 2022)
Table 10. Global Market Neuroblastoma Treatment Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Neuroblastoma Treatment Sales Sites and Area Served
Table 12. Manufacturers Neuroblastoma Treatment Product Type
Table 13. Global Neuroblastoma Treatment Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Neuroblastoma Treatment
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Neuroblastoma Treatment Market Challenges
Table 22. Global Neuroblastoma Treatment Sales by Type (Kilotons)
Table 23. Global Neuroblastoma Treatment Market Size by Type (M USD)
Table 24. Global Neuroblastoma Treatment Sales (Kilotons) by Type (2019-2024)
Table 25. Global Neuroblastoma Treatment Sales Market Share by Type (2019-2024)
Table 26. Global Neuroblastoma Treatment Market Size (M USD) by Type (2019-2024)
Table 27. Global Neuroblastoma Treatment Market Size Share by Type (2019-2024)
Table 28. Global Neuroblastoma Treatment Price (USD/Ton) by Type (2019-2024)
Table 29. Global Neuroblastoma Treatment Sales (Kilotons) by Application
Table 30. Global Neuroblastoma Treatment Market Size by Application
Table 31. Global Neuroblastoma Treatment Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Neuroblastoma Treatment Sales Market Share by Application (2019-2024)
Table 33. Global Neuroblastoma Treatment Sales by Application (2019-2024) & (M USD)
Table 34. Global Neuroblastoma Treatment Market Share by Application (2019-2024)
Table 35. Global Neuroblastoma Treatment Sales Growth Rate by Application (2019-2024)
Table 36. Global Neuroblastoma Treatment Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Neuroblastoma Treatment Sales Market Share by Region (2019-2024)
Table 38. North America Neuroblastoma Treatment Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Neuroblastoma Treatment Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Neuroblastoma Treatment Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Neuroblastoma Treatment Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Neuroblastoma Treatment Sales by Region (2019-2024) & (Kilotons)
Table 43. Seattle Children’s Neuroblastoma Treatment Basic Information
Table 44. Seattle Children’s Neuroblastoma Treatment Product Overview
Table 45. Seattle Children’s Neuroblastoma Treatment Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. Seattle Children’s Business Overview
Table 47. Seattle Children’s Neuroblastoma Treatment SWOT Analysis
Table 48. Seattle Children’s Recent Developments
Table 49. CureSearch Neuroblastoma Treatment Basic Information
Table 50. CureSearch Neuroblastoma Treatment Product Overview
Table 51. CureSearch Neuroblastoma Treatment Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. CureSearch Business Overview
Table 53. CureSearch Neuroblastoma Treatment SWOT Analysis
Table 54. CureSearch Recent Developments
Table 55. Texas Children’s Neuroblastoma Treatment Basic Information
Table 56. Texas Children’s Neuroblastoma Treatment Product Overview
Table 57. Texas Children’s Neuroblastoma Treatment Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. Texas Children’s Neuroblastoma Treatment SWOT Analysis
Table 59. Texas Children’s Business Overview
Table 60. Texas Children’s Recent Developments
Table 61. NANT Neuroblastoma Treatment Basic Information
Table 62. NANT Neuroblastoma Treatment Product Overview
Table 63. NANT Neuroblastoma Treatment Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. NANT Business Overview
Table 65. NANT Recent Developments
Table 66. Sino Biopharmaceutical Neuroblastoma Treatment Basic Information
Table 67. Sino Biopharmaceutical Neuroblastoma Treatment Product Overview
Table 68. Sino Biopharmaceutical Neuroblastoma Treatment Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. Sino Biopharmaceutical Business Overview
Table 70. Sino Biopharmaceutical Recent Developments
Table 71. Jiangsu Hengrui Medicine Co.,Ltd. Neuroblastoma Treatment Basic Information
Table 72. Jiangsu Hengrui Medicine Co.,Ltd. Neuroblastoma Treatment Product Overview
Table 73. Jiangsu Hengrui Medicine Co.,Ltd. Neuroblastoma Treatment Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 74. Jiangsu Hengrui Medicine Co.,Ltd. Business Overview
Table 75. Jiangsu Hengrui Medicine Co.,Ltd. Recent Developments
Table 76. Fosun Pharmaceutical Neuroblastoma Treatment Basic Information
Table 77. Fosun Pharmaceutical Neuroblastoma Treatment Product Overview
Table 78. Fosun Pharmaceutical Neuroblastoma Treatment Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 79. Fosun Pharmaceutical Business Overview
Table 80. Fosun Pharmaceutical Recent Developments
Table 81. Novartis Neuroblastoma Treatment Basic Information
Table 82. Novartis Neuroblastoma Treatment Product Overview
Table 83. Novartis Neuroblastoma Treatment Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 84. Novartis Business Overview
Table 85. Novartis Recent Developments
Table 86. Juno Therapeutics Neuroblastoma Treatment Basic Information
Table 87. Juno Therapeutics Neuroblastoma Treatment Product Overview
Table 88. Juno Therapeutics Neuroblastoma Treatment Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 89. Juno Therapeutics Business Overview
Table 90. Juno Therapeutics Recent Developments
Table 91. Kite Pharma Neuroblastoma Treatment Basic Information
Table 92. Kite Pharma Neuroblastoma Treatment Product Overview
Table 93. Kite Pharma Neuroblastoma Treatment Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 94. Kite Pharma Business Overview
Table 95. Kite Pharma Recent Developments
Table 96. Adaptimmune Neuroblastoma Treatment Basic Information
Table 97. Adaptimmune Neuroblastoma Treatment Product Overview
Table 98. Adaptimmune Neuroblastoma Treatment Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 99. Adaptimmune Business Overview
Table 100. Adaptimmune Recent Developments
Table 101. Global Neuroblastoma Treatment Sales Forecast by Region (2025-2030) & (Kilotons)
Table 102. Global Neuroblastoma Treatment Market Size Forecast by Region (2025-2030) & (M USD)
Table 103. North America Neuroblastoma Treatment Sales Forecast by Country (2025-2030) & (Kilotons)
Table 104. North America Neuroblastoma Treatment Market Size Forecast by Country (2025-2030) & (M USD)
Table 105. Europe Neuroblastoma Treatment Sales Forecast by Country (2025-2030) & (Kilotons)
Table 106. Europe Neuroblastoma Treatment Market Size Forecast by Country (2025-2030) & (M USD)
Table 107. Asia Pacific Neuroblastoma Treatment Sales Forecast by Region (2025-2030) & (Kilotons)
Table 108. Asia Pacific Neuroblastoma Treatment Market Size Forecast by Region (2025-2030) & (M USD)
Table 109. South America Neuroblastoma Treatment Sales Forecast by Country (2025-2030) & (Kilotons)
Table 110. South America Neuroblastoma Treatment Market Size Forecast by Country (2025-2030) & (M USD)
Table 111. Middle East and Africa Neuroblastoma Treatment Consumption Forecast by Country (2025-2030) & (Units)
Table 112. Middle East and Africa Neuroblastoma Treatment Market Size Forecast by Country (2025-2030) & (M USD)
Table 113. Global Neuroblastoma Treatment Sales Forecast by Type (2025-2030) & (Kilotons)
Table 114. Global Neuroblastoma Treatment Market Size Forecast by Type (2025-2030) & (M USD)
Table 115. Global Neuroblastoma Treatment Price Forecast by Type (2025-2030) & (USD/Ton)
Table 116. Global Neuroblastoma Treatment Sales (Kilotons) Forecast by Application (2025-2030)
Table 117. Global Neuroblastoma Treatment Market Size Forecast by Application (2025-2030) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Neuroblastoma Treatment Market Size Comparison by Region (M USD)
Table 5. Global Neuroblastoma Treatment Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Neuroblastoma Treatment Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Neuroblastoma Treatment Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Neuroblastoma Treatment Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neuroblastoma Treatment as of 2022)
Table 10. Global Market Neuroblastoma Treatment Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Neuroblastoma Treatment Sales Sites and Area Served
Table 12. Manufacturers Neuroblastoma Treatment Product Type
Table 13. Global Neuroblastoma Treatment Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Neuroblastoma Treatment
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Neuroblastoma Treatment Market Challenges
Table 22. Global Neuroblastoma Treatment Sales by Type (Kilotons)
Table 23. Global Neuroblastoma Treatment Market Size by Type (M USD)
Table 24. Global Neuroblastoma Treatment Sales (Kilotons) by Type (2019-2024)
Table 25. Global Neuroblastoma Treatment Sales Market Share by Type (2019-2024)
Table 26. Global Neuroblastoma Treatment Market Size (M USD) by Type (2019-2024)
Table 27. Global Neuroblastoma Treatment Market Size Share by Type (2019-2024)
Table 28. Global Neuroblastoma Treatment Price (USD/Ton) by Type (2019-2024)
Table 29. Global Neuroblastoma Treatment Sales (Kilotons) by Application
Table 30. Global Neuroblastoma Treatment Market Size by Application
Table 31. Global Neuroblastoma Treatment Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Neuroblastoma Treatment Sales Market Share by Application (2019-2024)
Table 33. Global Neuroblastoma Treatment Sales by Application (2019-2024) & (M USD)
Table 34. Global Neuroblastoma Treatment Market Share by Application (2019-2024)
Table 35. Global Neuroblastoma Treatment Sales Growth Rate by Application (2019-2024)
Table 36. Global Neuroblastoma Treatment Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Neuroblastoma Treatment Sales Market Share by Region (2019-2024)
Table 38. North America Neuroblastoma Treatment Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Neuroblastoma Treatment Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Neuroblastoma Treatment Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Neuroblastoma Treatment Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Neuroblastoma Treatment Sales by Region (2019-2024) & (Kilotons)
Table 43. Seattle Children’s Neuroblastoma Treatment Basic Information
Table 44. Seattle Children’s Neuroblastoma Treatment Product Overview
Table 45. Seattle Children’s Neuroblastoma Treatment Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. Seattle Children’s Business Overview
Table 47. Seattle Children’s Neuroblastoma Treatment SWOT Analysis
Table 48. Seattle Children’s Recent Developments
Table 49. CureSearch Neuroblastoma Treatment Basic Information
Table 50. CureSearch Neuroblastoma Treatment Product Overview
Table 51. CureSearch Neuroblastoma Treatment Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. CureSearch Business Overview
Table 53. CureSearch Neuroblastoma Treatment SWOT Analysis
Table 54. CureSearch Recent Developments
Table 55. Texas Children’s Neuroblastoma Treatment Basic Information
Table 56. Texas Children’s Neuroblastoma Treatment Product Overview
Table 57. Texas Children’s Neuroblastoma Treatment Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. Texas Children’s Neuroblastoma Treatment SWOT Analysis
Table 59. Texas Children’s Business Overview
Table 60. Texas Children’s Recent Developments
Table 61. NANT Neuroblastoma Treatment Basic Information
Table 62. NANT Neuroblastoma Treatment Product Overview
Table 63. NANT Neuroblastoma Treatment Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. NANT Business Overview
Table 65. NANT Recent Developments
Table 66. Sino Biopharmaceutical Neuroblastoma Treatment Basic Information
Table 67. Sino Biopharmaceutical Neuroblastoma Treatment Product Overview
Table 68. Sino Biopharmaceutical Neuroblastoma Treatment Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. Sino Biopharmaceutical Business Overview
Table 70. Sino Biopharmaceutical Recent Developments
Table 71. Jiangsu Hengrui Medicine Co.,Ltd. Neuroblastoma Treatment Basic Information
Table 72. Jiangsu Hengrui Medicine Co.,Ltd. Neuroblastoma Treatment Product Overview
Table 73. Jiangsu Hengrui Medicine Co.,Ltd. Neuroblastoma Treatment Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 74. Jiangsu Hengrui Medicine Co.,Ltd. Business Overview
Table 75. Jiangsu Hengrui Medicine Co.,Ltd. Recent Developments
Table 76. Fosun Pharmaceutical Neuroblastoma Treatment Basic Information
Table 77. Fosun Pharmaceutical Neuroblastoma Treatment Product Overview
Table 78. Fosun Pharmaceutical Neuroblastoma Treatment Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 79. Fosun Pharmaceutical Business Overview
Table 80. Fosun Pharmaceutical Recent Developments
Table 81. Novartis Neuroblastoma Treatment Basic Information
Table 82. Novartis Neuroblastoma Treatment Product Overview
Table 83. Novartis Neuroblastoma Treatment Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 84. Novartis Business Overview
Table 85. Novartis Recent Developments
Table 86. Juno Therapeutics Neuroblastoma Treatment Basic Information
Table 87. Juno Therapeutics Neuroblastoma Treatment Product Overview
Table 88. Juno Therapeutics Neuroblastoma Treatment Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 89. Juno Therapeutics Business Overview
Table 90. Juno Therapeutics Recent Developments
Table 91. Kite Pharma Neuroblastoma Treatment Basic Information
Table 92. Kite Pharma Neuroblastoma Treatment Product Overview
Table 93. Kite Pharma Neuroblastoma Treatment Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 94. Kite Pharma Business Overview
Table 95. Kite Pharma Recent Developments
Table 96. Adaptimmune Neuroblastoma Treatment Basic Information
Table 97. Adaptimmune Neuroblastoma Treatment Product Overview
Table 98. Adaptimmune Neuroblastoma Treatment Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 99. Adaptimmune Business Overview
Table 100. Adaptimmune Recent Developments
Table 101. Global Neuroblastoma Treatment Sales Forecast by Region (2025-2030) & (Kilotons)
Table 102. Global Neuroblastoma Treatment Market Size Forecast by Region (2025-2030) & (M USD)
Table 103. North America Neuroblastoma Treatment Sales Forecast by Country (2025-2030) & (Kilotons)
Table 104. North America Neuroblastoma Treatment Market Size Forecast by Country (2025-2030) & (M USD)
Table 105. Europe Neuroblastoma Treatment Sales Forecast by Country (2025-2030) & (Kilotons)
Table 106. Europe Neuroblastoma Treatment Market Size Forecast by Country (2025-2030) & (M USD)
Table 107. Asia Pacific Neuroblastoma Treatment Sales Forecast by Region (2025-2030) & (Kilotons)
Table 108. Asia Pacific Neuroblastoma Treatment Market Size Forecast by Region (2025-2030) & (M USD)
Table 109. South America Neuroblastoma Treatment Sales Forecast by Country (2025-2030) & (Kilotons)
Table 110. South America Neuroblastoma Treatment Market Size Forecast by Country (2025-2030) & (M USD)
Table 111. Middle East and Africa Neuroblastoma Treatment Consumption Forecast by Country (2025-2030) & (Units)
Table 112. Middle East and Africa Neuroblastoma Treatment Market Size Forecast by Country (2025-2030) & (M USD)
Table 113. Global Neuroblastoma Treatment Sales Forecast by Type (2025-2030) & (Kilotons)
Table 114. Global Neuroblastoma Treatment Market Size Forecast by Type (2025-2030) & (M USD)
Table 115. Global Neuroblastoma Treatment Price Forecast by Type (2025-2030) & (USD/Ton)
Table 116. Global Neuroblastoma Treatment Sales (Kilotons) Forecast by Application (2025-2030)
Table 117. Global Neuroblastoma Treatment Market Size Forecast by Application (2025-2030) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Neuroblastoma Treatment
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Neuroblastoma Treatment Market Size (M USD), 2019-2030
Figure 5. Global Neuroblastoma Treatment Market Size (M USD) (2019-2030)
Figure 6. Global Neuroblastoma Treatment Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Neuroblastoma Treatment Market Size by Country (M USD)
Figure 11. Neuroblastoma Treatment Sales Share by Manufacturers in 2023
Figure 12. Global Neuroblastoma Treatment Revenue Share by Manufacturers in 2023
Figure 13. Neuroblastoma Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Neuroblastoma Treatment Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Neuroblastoma Treatment Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Neuroblastoma Treatment Market Share by Type
Figure 18. Sales Market Share of Neuroblastoma Treatment by Type (2019-2024)
Figure 19. Sales Market Share of Neuroblastoma Treatment by Type in 2023
Figure 20. Market Size Share of Neuroblastoma Treatment by Type (2019-2024)
Figure 21. Market Size Market Share of Neuroblastoma Treatment by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Neuroblastoma Treatment Market Share by Application
Figure 24. Global Neuroblastoma Treatment Sales Market Share by Application (2019-2024)
Figure 25. Global Neuroblastoma Treatment Sales Market Share by Application in 2023
Figure 26. Global Neuroblastoma Treatment Market Share by Application (2019-2024)
Figure 27. Global Neuroblastoma Treatment Market Share by Application in 2023
Figure 28. Global Neuroblastoma Treatment Sales Growth Rate by Application (2019-2024)
Figure 29. Global Neuroblastoma Treatment Sales Market Share by Region (2019-2024)
Figure 30. North America Neuroblastoma Treatment Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Neuroblastoma Treatment Sales Market Share by Country in 2023
Figure 32. U.S. Neuroblastoma Treatment Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Neuroblastoma Treatment Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Neuroblastoma Treatment Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Neuroblastoma Treatment Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Neuroblastoma Treatment Sales Market Share by Country in 2023
Figure 37. Germany Neuroblastoma Treatment Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Neuroblastoma Treatment Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Neuroblastoma Treatment Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Neuroblastoma Treatment Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Neuroblastoma Treatment Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Neuroblastoma Treatment Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Neuroblastoma Treatment Sales Market Share by Region in 2023
Figure 44. China Neuroblastoma Treatment Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Neuroblastoma Treatment Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Neuroblastoma Treatment Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Neuroblastoma Treatment Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Neuroblastoma Treatment Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Neuroblastoma Treatment Sales and Growth Rate (Kilotons)
Figure 50. South America Neuroblastoma Treatment Sales Market Share by Country in 2023
Figure 51. Brazil Neuroblastoma Treatment Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Neuroblastoma Treatment Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Neuroblastoma Treatment Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Neuroblastoma Treatment Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Neuroblastoma Treatment Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Neuroblastoma Treatment Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Neuroblastoma Treatment Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Neuroblastoma Treatment Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Neuroblastoma Treatment Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Neuroblastoma Treatment Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Neuroblastoma Treatment Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Neuroblastoma Treatment Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Neuroblastoma Treatment Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Neuroblastoma Treatment Market Share Forecast by Type (2025-2030)
Figure 65. Global Neuroblastoma Treatment Sales Forecast by Application (2025-2030)
Figure 66. Global Neuroblastoma Treatment Market Share Forecast by Application (2025-2030)
Figure 1. Product Picture of Neuroblastoma Treatment
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Neuroblastoma Treatment Market Size (M USD), 2019-2030
Figure 5. Global Neuroblastoma Treatment Market Size (M USD) (2019-2030)
Figure 6. Global Neuroblastoma Treatment Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Neuroblastoma Treatment Market Size by Country (M USD)
Figure 11. Neuroblastoma Treatment Sales Share by Manufacturers in 2023
Figure 12. Global Neuroblastoma Treatment Revenue Share by Manufacturers in 2023
Figure 13. Neuroblastoma Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Neuroblastoma Treatment Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Neuroblastoma Treatment Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Neuroblastoma Treatment Market Share by Type
Figure 18. Sales Market Share of Neuroblastoma Treatment by Type (2019-2024)
Figure 19. Sales Market Share of Neuroblastoma Treatment by Type in 2023
Figure 20. Market Size Share of Neuroblastoma Treatment by Type (2019-2024)
Figure 21. Market Size Market Share of Neuroblastoma Treatment by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Neuroblastoma Treatment Market Share by Application
Figure 24. Global Neuroblastoma Treatment Sales Market Share by Application (2019-2024)
Figure 25. Global Neuroblastoma Treatment Sales Market Share by Application in 2023
Figure 26. Global Neuroblastoma Treatment Market Share by Application (2019-2024)
Figure 27. Global Neuroblastoma Treatment Market Share by Application in 2023
Figure 28. Global Neuroblastoma Treatment Sales Growth Rate by Application (2019-2024)
Figure 29. Global Neuroblastoma Treatment Sales Market Share by Region (2019-2024)
Figure 30. North America Neuroblastoma Treatment Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Neuroblastoma Treatment Sales Market Share by Country in 2023
Figure 32. U.S. Neuroblastoma Treatment Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Neuroblastoma Treatment Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Neuroblastoma Treatment Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Neuroblastoma Treatment Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Neuroblastoma Treatment Sales Market Share by Country in 2023
Figure 37. Germany Neuroblastoma Treatment Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Neuroblastoma Treatment Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Neuroblastoma Treatment Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Neuroblastoma Treatment Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Neuroblastoma Treatment Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Neuroblastoma Treatment Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Neuroblastoma Treatment Sales Market Share by Region in 2023
Figure 44. China Neuroblastoma Treatment Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Neuroblastoma Treatment Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Neuroblastoma Treatment Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Neuroblastoma Treatment Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Neuroblastoma Treatment Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Neuroblastoma Treatment Sales and Growth Rate (Kilotons)
Figure 50. South America Neuroblastoma Treatment Sales Market Share by Country in 2023
Figure 51. Brazil Neuroblastoma Treatment Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Neuroblastoma Treatment Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Neuroblastoma Treatment Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Neuroblastoma Treatment Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Neuroblastoma Treatment Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Neuroblastoma Treatment Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Neuroblastoma Treatment Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Neuroblastoma Treatment Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Neuroblastoma Treatment Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Neuroblastoma Treatment Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Neuroblastoma Treatment Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Neuroblastoma Treatment Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Neuroblastoma Treatment Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Neuroblastoma Treatment Market Share Forecast by Type (2025-2030)
Figure 65. Global Neuroblastoma Treatment Sales Forecast by Application (2025-2030)
Figure 66. Global Neuroblastoma Treatment Market Share Forecast by Application (2025-2030)
